FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2022060392> ?p ?o ?g. }

• W2022060392 endingPage "380" @default.
• W2022060392 startingPage "374" @default.
• W2022060392 abstract "PURPOSE Macrophage inflammatory protein-3α (Mip-3α) is part of a family of chemotactic cytokines involved in recruiting inflammatory cells throughout the body. CCR6 is a G-protein-linked, seven-trans-membrane receptor that is highly specific for Mip-3α. The role of Mip-3α has been well defined in several inflammatory conditions, but its role has not been well defined in neoplastic processes. Mip-3α has been shown to promote pancreatic cancer cell migration, but no studies have demonstrated the effect of Mip-3α on pancreatic cancer cell invasion. We hypothesize that Mip-3α and its CCR6 receptor promote pancreatic cancer cell invasion. MATERIALS AND METHODS Immunohistochemical staining was performed for Mip-3α and CCR6 in pancreatic cancer tissue and the human pancreatic cancer cell line PANC-1. RNA was isolated from PANC-1 cancer cells, and the presence of Mip-3α messenger RNA in PANC-1 cancer cells was determined by reverse transcriptase polymerase chain reaction. PANC-1 cancer cell invasion of type IV collagen was evaluated in the presence of Mip-3α and anti-CCR6 antibody with the use of a modified Boyden chamber invasion assay. RESULTS Co-localization of Mip-3α and its CCR6 receptor in pancreatic cancer was confirmed using immunohistochemical staining for Mip-3α and its CCR6 receptor and reverse transcriptase polymerase chain reaction for Mip-3α. Immunohistochemical staining of pancreatic cancer tissue and the PANC-1 cancer cell line showed positive staining for Mip-3α and its CCR6 receptor within the cancer cells. Staining was also positive for Mip-3α within stromal cells adjacent to the cancer cells in pancreatic cancer tissue. Reverse transcriptase polymerase chain reaction demonstrated the presence of Mip-3α messenger RNA within PANC-1 cancer cells. Invasion studies showed that increasing concentrations of Mip-3α promoted a dose-dependent increase in pancreatic cancer cell invasion of type IV collagen. The addition of 100 ng/mL of Mip-3α promoted a threefold increase in pancreatic cancer cell invasion over that of the control group. Anti-CCR6 antibody inhibited Mip-3α-stimulated PANC-1 cancer cell invasion of type IV collagen by 63%. DISCUSSION Co-localization of Mip-3α and its CCR6 receptor promotes pancreatic cancer cell invasion of type IV collagen. This finding continues to highlight the importance that inflammation plays in the progression of pancreatic cancer. As the relationship between the inflammatory and neoplastic processes involved with pancreatic cancer becomes better defined, therapies targeting the inflammatory process may help prevent pancreatic cancer invasion and metastasis." @default.
• W2022060392 created "2016-06-24" @default.
• W2022060392 creator A5018897037 @default.
• W2022060392 creator A5052278096 @default.
• W2022060392 creator A5070632726 @default.
• W2022060392 creator A5076099306 @default.
• W2022060392 creator A5090202950 @default.
• W2022060392 date "2004-11-01" @default.
• W2022060392 modified "2023-10-17" @default.
• W2022060392 title "Co-localization of Macrophage Inflammatory Protein-3?? (Mip-3??) and Its Receptor, CCR6, Promotes Pancreatic Cancer Cell Invasion" @default.
• W2022060392 cites W1534594872 @default.
• W2022060392 cites W1568573049 @default.
• W2022060392 cites W1930757563 @default.
• W2022060392 cites W1941870955 @default.
• W2022060392 cites W1974219858 @default.
• W2022060392 cites W1987389989 @default.
• W2022060392 cites W1998470464 @default.
• W2022060392 cites W2004690317 @default.
• W2022060392 cites W2005660567 @default.
• W2022060392 cites W2013729937 @default.
• W2022060392 cites W2016397844 @default.
• W2022060392 cites W2019931906 @default.
• W2022060392 cites W2059413226 @default.
• W2022060392 cites W2076744242 @default.
• W2022060392 cites W2089166784 @default.
• W2022060392 cites W2091188319 @default.
• W2022060392 cites W209718637 @default.
• W2022060392 cites W2111736523 @default.
• W2022060392 cites W2124617998 @default.
• W2022060392 cites W2126246192 @default.
• W2022060392 cites W2134326405 @default.
• W2022060392 cites W2142546120 @default.
• W2022060392 cites W2156082292 @default.
• W2022060392 cites W2315695983 @default.
• W2022060392 cites W4205129348 @default.
• W2022060392 cites W4211264883 @default.
• W2022060392 cites W4241578751 @default.
• W2022060392 cites W4255992830 @default.
• W2022060392 cites W4313333699 @default.
• W2022060392 cites W4378836381 @default.
• W2022060392 doi "https://doi.org/10.1097/00130404-200411000-00007" @default.
• W2022060392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15701269" @default.
• W2022060392 hasPublicationYear "2004" @default.
• W2022060392 type Work @default.
• W2022060392 sameAs 2022060392 @default.
• W2022060392 citedByCount "80" @default.
• W2022060392 countsByYear W20220603922012 @default.
• W2022060392 countsByYear W20220603922013 @default.
• W2022060392 countsByYear W20220603922014 @default.
• W2022060392 countsByYear W20220603922015 @default.
• W2022060392 countsByYear W20220603922016 @default.
• W2022060392 countsByYear W20220603922017 @default.
• W2022060392 countsByYear W20220603922018 @default.
• W2022060392 countsByYear W20220603922019 @default.
• W2022060392 countsByYear W20220603922020 @default.
• W2022060392 countsByYear W20220603922021 @default.
• W2022060392 countsByYear W20220603922022 @default.
• W2022060392 countsByYear W20220603922023 @default.
• W2022060392 crossrefType "journal-article" @default.
• W2022060392 hasAuthorship W2022060392A5018897037 @default.
• W2022060392 hasAuthorship W2022060392A5052278096 @default.
• W2022060392 hasAuthorship W2022060392A5070632726 @default.
• W2022060392 hasAuthorship W2022060392A5076099306 @default.
• W2022060392 hasAuthorship W2022060392A5090202950 @default.
• W2022060392 hasConcept C121608353 @default.
• W2022060392 hasConcept C12823836 @default.
• W2022060392 hasConcept C13373296 @default.
• W2022060392 hasConcept C142724271 @default.
• W2022060392 hasConcept C153911025 @default.
• W2022060392 hasConcept C170493617 @default.
• W2022060392 hasConcept C203014093 @default.
• W2022060392 hasConcept C204232928 @default.
• W2022060392 hasConcept C2779013556 @default.
• W2022060392 hasConcept C2780210213 @default.
• W2022060392 hasConcept C502942594 @default.
• W2022060392 hasConcept C54355233 @default.
• W2022060392 hasConcept C55493867 @default.
• W2022060392 hasConcept C71924100 @default.
• W2022060392 hasConcept C86803240 @default.
• W2022060392 hasConcept C94205230 @default.
• W2022060392 hasConcept C96232424 @default.
• W2022060392 hasConceptScore W2022060392C121608353 @default.
• W2022060392 hasConceptScore W2022060392C12823836 @default.
• W2022060392 hasConceptScore W2022060392C13373296 @default.
• W2022060392 hasConceptScore W2022060392C142724271 @default.
• W2022060392 hasConceptScore W2022060392C153911025 @default.
• W2022060392 hasConceptScore W2022060392C170493617 @default.
• W2022060392 hasConceptScore W2022060392C203014093 @default.
• W2022060392 hasConceptScore W2022060392C204232928 @default.
• W2022060392 hasConceptScore W2022060392C2779013556 @default.
• W2022060392 hasConceptScore W2022060392C2780210213 @default.
• W2022060392 hasConceptScore W2022060392C502942594 @default.
• W2022060392 hasConceptScore W2022060392C54355233 @default.
• W2022060392 hasConceptScore W2022060392C55493867 @default.
• W2022060392 hasConceptScore W2022060392C71924100 @default.
• W2022060392 hasConceptScore W2022060392C86803240 @default.
• W2022060392 hasConceptScore W2022060392C94205230 @default.
• W2022060392 hasConceptScore W2022060392C96232424 @default.

• next